arrow
N

Nichole R. Klatt

University of Minnesota
H指数:47
被引数:9,066

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gut barrier integrity biomarkers are associated with increased inflammation and predict disease status in hospitalized COVID-19 patients

肠道屏障完整性生物标志物与炎症增加相关,并预测住院COVID-19患者的疾病状态

2026-07-030
OA
The vaginal microbiome of pregnant people living with HIV on antiretroviral therapy in the Democratic Republic of Congo: a pilot study and global meta-analysis

刚果民主共和国接受抗逆转录病毒治疗的HIV感染者孕妇的阴道微生物组:一项试点研究和全球荟萃分析

mSphere
IF3.1
2026-01-010
PRE
Distinct gastrointestinal microbial signatures predict parasite levels in controlled Plasmodium infections in both rhesus macaques and humans

独特的肠道微生物特征可预测在恒河猴和人类中受控的疟原虫感染中的寄生虫水平。

2025-12-190
OAAI
SARS-CoV-2 infectivity can be modulated through bacterial grooming of the glycocalyx

SARS-CoV-2感染性可以通过糖萼的细菌修饰来调节

MBIO
IF4.7
2025-02-250
OAAI
SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized patients
2024-11-050
OAAI
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019

在冠状病毒病2019的随机,安慰剂对照临床试验中,二甲双胍对新型冠状病毒病毒载量的良好抗病毒作用

2024-05-0111
PRE
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT) : a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial

10个月内新型冠状病毒肺炎的门诊治疗和post-COVID-19状况的发生率 (covid-out): 一项多中心,随机,四盲,平行组,3期试验

2023-10-0192
OAAI
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial

Covid-out试验中新型冠状病毒 (SARS-CoV-2) 疫苗接种和加强对冠状病毒病2019 (新型冠状病毒肺炎) 症状严重程度随时间的影响

2022-09-179
OA
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
2022-08-18161
OA